359P Overall survival of palbociclib (PAL) + endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study

Saved in:
Bibliographic Details
Title: 359P Overall survival of palbociclib (PAL) + endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study
Authors: Nakayama, T.1 (AUTHOR), Nagai, S.E.2 (AUTHOR), Hattori, M.3 (AUTHOR), Yoshinami, T.4 (AUTHOR), Masuda, H.5 (AUTHOR), Okamura, T.6 (AUTHOR), Watanabe, K-I.7 (AUTHOR), Tsuneizumi, M.8 (AUTHOR), Takabatake, D.9 (AUTHOR), Harao, M.10 (AUTHOR), Yasojima, H.11 (AUTHOR), Oshiro, C.12 (AUTHOR), Iwase, M.13 (AUTHOR), Yamaguchi, M.14 (AUTHOR), Sangai, T.15 (AUTHOR), Sasada, S.16 (AUTHOR), Ishida, T.17 (AUTHOR), Futamura, M.18 (AUTHOR), Kosaka, N.19 (AUTHOR), Masuda, N.20 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS368-S368. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179691717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 359P Overall survival of palbociclib (PAL) + endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Nakayama%2C+T%2E%22">Nakayama, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nagai%2C+S%2EE%2E%22">Nagai, S.E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hattori%2C+M%2E%22">Hattori, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yoshinami%2C+T%2E%22">Yoshinami, T.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Masuda%2C+H%2E%22">Masuda, H.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Okamura%2C+T%2E%22">Okamura, T.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Watanabe%2C+K-I%2E%22">Watanabe, K-I.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsuneizumi%2C+M%2E%22">Tsuneizumi, M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Takabatake%2C+D%2E%22">Takabatake, D.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harao%2C+M%2E%22">Harao, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yasojima%2C+H%2E%22">Yasojima, H.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oshiro%2C+C%2E%22">Oshiro, C.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Iwase%2C+M%2E%22">Iwase, M.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamaguchi%2C+M%2E%22">Yamaguchi, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sangai%2C+T%2E%22">Sangai, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sasada%2C+S%2E%22">Sasada, S.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ishida%2C+T%2E%22">Ishida, T.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Futamura%2C+M%2E%22">Futamura, M.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kosaka%2C+N%2E%22">Kosaka, N.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Masuda%2C+N%2E%22">Masuda, N.</searchLink><relatesTo>20</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS368-S368. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179691717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.307
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S368
    Titles:
      – TitleFull: 359P Overall survival of palbociclib (PAL) + endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakayama, T.
      – PersonEntity:
          Name:
            NameFull: Nagai, S.E.
      – PersonEntity:
          Name:
            NameFull: Hattori, M.
      – PersonEntity:
          Name:
            NameFull: Yoshinami, T.
      – PersonEntity:
          Name:
            NameFull: Masuda, H.
      – PersonEntity:
          Name:
            NameFull: Okamura, T.
      – PersonEntity:
          Name:
            NameFull: Watanabe, K-I.
      – PersonEntity:
          Name:
            NameFull: Tsuneizumi, M.
      – PersonEntity:
          Name:
            NameFull: Takabatake, D.
      – PersonEntity:
          Name:
            NameFull: Harao, M.
      – PersonEntity:
          Name:
            NameFull: Yasojima, H.
      – PersonEntity:
          Name:
            NameFull: Oshiro, C.
      – PersonEntity:
          Name:
            NameFull: Iwase, M.
      – PersonEntity:
          Name:
            NameFull: Yamaguchi, M.
      – PersonEntity:
          Name:
            NameFull: Sangai, T.
      – PersonEntity:
          Name:
            NameFull: Sasada, S.
      – PersonEntity:
          Name:
            NameFull: Ishida, T.
      – PersonEntity:
          Name:
            NameFull: Futamura, M.
      – PersonEntity:
          Name:
            NameFull: Kosaka, N.
      – PersonEntity:
          Name:
            NameFull: Masuda, N.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1